iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
22 Mar, 2024
iTrack™ Canaloplasty to be Featured at the 2024 American Glaucoma Society (AGS) Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
23 Jan, 2024
6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty
Media Release iTrack
2 Nov, 2023
Preliminary Clinical Data Highlights Potential to Expand Addressable Market to include Angle Closure Glaucoma
Media Release iTrack
25 Oct, 2023
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
Media Release General iTrack Molteno3 AlphaRET
1 Sept, 2023
iTrack™ Advance to be Featured at the 10th World Glaucoma Congress
Media Release iTrack
23 June, 2023
iTrack™ Canaloplasty to be Featured at the Congress of German Ophthalmic Surgery (DOC) 2023
Media Release General iTrack Molteno3 AlphaRET
15 June, 2023
iTrack™ Advance to be Featured at 35th APACRS Annual Meeting, Singapore
Media Release iTrack
8 June, 2023
iTrack™ Canaloplasty to be Featured in Numerous Scientific Presentations at the ASCRS 2023 Annual Meeting
Media Release iTrack
4 May, 2023
iTrack™ Canaloplasty to be Featured at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Media Release iTrack
23 Apr, 2023
USA Clearance of iTrack™ Advance Canaloplasty Device
Media Release iTrack
12 Apr, 2023
iTrack™ Canaloplasty to be Featured at the 2023 American Glaucoma Society (AGS) Annual Meeting
Media Release iTrack
7 Mar, 2023
iTrack™ Canaloplasty to be Featured at the 2023 American Glaucoma Society (AGS) Annual Meeting
Media Release iTrack
3 Mar, 2023
iTrack™ Canaloplasty to be Featured at the 2023 Asia-Pacific Academy of Ophthalmology Congress (APAO)
Media Release iTrack
23 Feb, 2023
Nova Eye Medical Launches Multi-Center ‘CATALYST’ Study in Europe to Investigate Canaloplasty with the new iTrack™ Advance
Media Release iTrack
11 Aug, 2022
Nova Eye Medical Announces Global Data Registry to Support Role of Canaloplasty for Glaucoma
Media Release iTrack
4 Aug, 2022
Peer Review Publication of 36- and 48-month Canaloplasty Data Demonstrates Sustained Reduction in IOP with iTrack™
Media Release iTrack
5 May, 2022
Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
Media Release General iTrack
19 Apr, 2022
iTrack™ Canaloplasty to be Featured at the 2022 ASCRS Annual Meeting
Media Release General iTrack
12 Apr, 2022
Nova Eye, Inc., President Appointed to American Glaucoma Society (AGS) Foundation Advisory Board
Media Release General iTrack
31 Mar, 2022
iTrack™ to be Featured at the 2022 American Glaucoma Society (AGS) Annual Meeting
Media Release iTrack
8 Mar, 2022
One Year Evaluation of Endothelial Cell Density Following iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
5-Year Effectiveness and Safety Data for iTrack™ to be Spotlighted at ESCRS 2021
Media Release General iTrack
8 Oct, 2021
Long-Term Effectiveness of iTrack™ MIGS Procedure to be Spotlighted at 2021 Swiss Society of Ophthalmology
Media Release General iTrack
25 Aug, 2021
2RT® Featured at the 2021 Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
Media Release General AlphaRET
3 May, 2021
Nova Eye Medical Announces First Patient Enrolled in “MAGIC” Multi-Center Canaloplasty Trial for Glaucoma
Media Release General iTrack
30 Apr, 2021
24-Month iTrack™ Data Demonstrate Real-World Efficacy of Canaloplasty as Standalone and Combined MIGS Procedure
Media Release General iTrack
20 Apr, 2021
For media enquires please contact:
Kate Hunt
Nova Eye Medical Limited
W +61 404 080 679
khunt@nova-eye.com